#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13978	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2247	619.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1490	1490	C	796	C	732	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13978	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2247	619.4	0	HET	.	.	.	C207T	.	207	207	C	513	513	C	776	C,T	536,174	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25386	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3554	712.3	0	.	n	.	0	T695C	SNP	695	695	T	1019	1019	C	767	C,T	707,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25386	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3554	712.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2295	2295	C	776	C	720	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25386	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3554	712.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2369	2369	A	770	A,G	730,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25386	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3554	712.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2921	2921	C	810	C,T	744,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1902	folP	855	855	100.0	folP.l6.c4.ctg.1	1446	130.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1009	1011	AGC	194;194;197	A;G;C	180;181;181	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5442	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3418	158.8	1	SNP	p	S91F	1	.	.	271	273	TTC	594	596	TTC	189;190;190	T;T;C	175;177;176	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5442	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3418	158.8	1	SNP	p	D95G	1	.	.	283	285	GGC	606	608	GGC	185;186;188	G;G,T;C	168;167,1;172	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5442	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3418	158.8	1	SNP	p	G95N	0	.	.	283	285	GGC	606	608	GGC	185;186;188	G;G,T;C	168;167,1;172	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1662	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1310	126.4	1	SNP	p	G45D	0	.	.	133	135	GGC	480	482	GGC	237;237;238	G;G;C	222;218;220	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	900	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	973	91.9	0	.	n	.	0	A197.	DEL	197	197	A	598	598	A	213	A	203	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5234	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2901	179.5	1	SNP	p	D86N	0	.	.	256	258	GAC	585	587	GAC	207;208;208	G;A;C	191;188;190	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5234	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2901	179.5	1	SNP	p	R87W	0	.	.	259	261	CGT	588	590	CGT	208;210;208	C;G;T	192;192;188	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5234	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2901	179.5	1	SNP	p	S87R	1	.	.	259	261	CGT	588	590	CGT	208;210;208	C;G;T	192;192;188	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5234	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2901	179.5	1	SNP	p	R87I	0	.	.	259	261	CGT	588	590	CGT	208;210;208	C;G;T	192;192;188	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5234	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2901	179.5	1	SNP	p	S88P	0	.	.	262	264	TCC	591	593	TCC	206;203;201	T;C;C	189;189;186	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3974	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2667	148.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1606	1608	GGC	186;183;184	G;G;C	174;171;172	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4004	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2371	168.1	1	SNP	p	A311V	0	.	.	931	933	GCC	1266	1268	GCC	211;214;213	G;C;C	195;196;197	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4004	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2371	168.1	1	SNP	p	I312M	1	.	.	934	936	ATG	1269	1271	ATG	215;215;217	A;T,C;G	198;195,1;197	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4004	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2371	168.1	1	SNP	p	T316P	0	.	.	946	948	ACC	1281	1283	ACC	208;205;204	A;C;C,A	189;188;184,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4004	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2371	168.1	1	SNP	p	V316T	1	.	.	946	948	ACC	1281	1283	ACC	208;205;204	A;C;C,A	189;188;184,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4004	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2371	168.1	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1782	1784	ACC	197;193;194	A;C;C	175;176;176	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4004	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2371	168.1	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1836	1838	GCG	199;200;201	G;C;G	187;189;191	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4004	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2371	168.1	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1836	1838	GCG	199;200;201	G;C;G	187;189;191	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4004	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2371	168.1	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1959	1961	GGT	159;159;161	G;G;T	147;150;151	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4004	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2371	168.1	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1968	1970	AGC	160;160;160	A;G;C	148;148;145	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4004	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2371	168.1	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1986	1988	CCG	155;159;160	C,G;C;G	121,7;126;124	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5758	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3063	187.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1601	1603	CCG	183;186;185	C;C,A;G	159;170,1;165	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2198	porA	1146	1146	99.91	porA.l15.c30.ctg.1	1696	128.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	588	588	C	156	C	141	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2984	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1483	199.6	0	.	p	.	0	I45V	NONSYN	133	135	ATT	436	438	GTT	223;225;227	G,A;T;T	210,1;210;212	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2984	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1483	199.6	1	SNP	p	G120K	1	.	.	358	360	AAG	661	663	AAG	275;275;278	A;A;G	254;256;253	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2984	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1483	199.6	1	SNP	p	A121N	1	.	.	361	363	AAC	664	666	AAC	276;272;271	A;A;C	256;254;251	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2984	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1483	199.6	1	SNP	p	N121D	0	.	.	361	363	AAC	664	666	AAC	276;272;271	A;A;C	256;254;251	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10620	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4960	213.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1110	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	888	123.7	1	SNP	p	V57M	1	.	.	169	171	ATG	453	455	ATG	238;237;238	A;T;G,T	218;216;218,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
